Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)
Sponsor: Aldeyra Therapeutics, Inc.
Summary
A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects with Moderate Alcohol Associated Hepatitis (Part 1)
Official title: A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects With Moderate Alcohol Associated Hepatitis
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
4
Start Date
2024-11-04
Completion Date
2025-06-18
Last Updated
2026-06-03
Healthy Volunteers
No
Conditions
Interventions
ADX-629
125 mg twice daily for 28 days
ADX-629
250 mg twice daily for 28 days
Locations (6)
Synergry Healthcare
Bradenton, Florida, United States
Florida Health Sciences Center/Tampa General Hospital/USF
Tampa, Florida, United States
The Liver Institute at Methodist Dallas Medical Center
Dallas, Texas, United States
UDL Clinical Research, LLC
Houston, Texas, United States
Methodist Specialty and Transplant Hospital
San Antonio, Texas, United States
Bon Secours Liver Institute of Newport News
Richmond, Virginia, United States